Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Knowledge of the mechanisms leading to MUC1 overexpression may help in the development of molecular approaches for breast cancer therapy.
|
10567695 |
1999 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
These results identify a genetic mechanism responsible for MUC1 gene overexpression and support the hypothesis that a gene dosage effect of the long arm of chromosome 1 may be involved in the pathogenesis of breast cancer.
|
9309122 |
1997 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Of particular relevance to breast cancer, steroid hormones also stimulate the expression of the MUC1 gene.
|
17083744 |
2006 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
While the malignant epithelial cells of pancreatic cancer show limited expression, in breast cancer tissue MUC1-ARF demonstrates strong nuclear expression.
|
27768738 |
2016 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
This study was aimed to bioinformatics analysis and designing a recombinant chimeric protein containing MUC1 and HER2 antigens to express in prokaryotic host (Escherichia coli) as breast cancer diagnosis tools.
|
25128064 |
2014 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
A comparison of the amounts of the 2 isoforms revealed preferential expression of the novel MUC1/Y protein in breast cancer tissue samples.
|
9180140 |
1997 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Effects of steroid-free fetal serum and steroid supplementation on MUC1 gene expression in human breast cancer cell line MCF7.
|
9066652 |
1997 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We propose that the plasma levels of miR-923 and CA 15-3, combined with standard clinicopathological predictors, could be used as a preoperative, noninvasive estimate of patient prognosis to identify which women might need more aggressive treatment or closer surveillance after surgery for breast cancer.
|
31607655 |
2019 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Inhibition of tumor recurrence was associated with significant serum level reductions of the human BC recurrence marker CA 15-3 at the study end in animals treated with OC.
|
31072015 |
2019 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The mucin MUC1, a type I transmembrane glycoprotein, is overexpressed in breast cancer and has been correlated with increased metastasis.
|
21798038 |
2011 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Our preliminary RT-PCR studies confirmed MUC1 expression by MDA-231 breast cancer cells.
|
10361508 |
1999 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
MUC1 mucin is a heavily O-glycosylated transmembrane protein that is aberrantly expressed in many carcinomas, including breast cancer.
|
12798775 |
2003 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
MUC1 mRNA expression was detected by RT-PCR in MCF-7 cells and in all 15 primary breast carcinomas but not in control lymph nodes taken from patients with benign diseases.
|
7520351 |
1994 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The oncoprotein MUC-1 was shown to upregulate the transcription of genes encoding cholesterol and lipid metabolic enzymes and correlated with a resistance to Tamoxifen (Tam) despite the presence of estrogen receptor α in breast cancer tumors.
|
23063783 |
2012 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Since it is known that anti-MUC1 antibodies may alter estrogen receptor activity in breast cancer, this potential interplay was investigated in OC.
|
30642093 |
2019 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
EF-2-treated mouse sera had significantly reduced CA 15-3 levels, the human BC recurrence marker, compared to the placebo control group at the end of the study.
|
31590382 |
2019 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.
|
10995787 |
2000 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
To gain further insights into the clinical relevance of rab31 and mucin-1 expression in breast cancer, we analyzed the relation between rab31 and mucin-1 (CA15-3) antigen levels in detergent tissue extracts of ER-positive (ER+) tumors and clinicopathological parameters as well as patients' prognosis.
|
28979817 |
2017 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Mucin1 (MUC1) is expressed ubiquitously on breast cancer cells and is a potential target for the generation of cytotoxic T cells for vaccination against breast cancer.
|
10706970 |
2000 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Blockade of MUC1 expression by glycerol guaiacolate inhibits proliferation of human breast cancer cells.
|
21184665 |
2010 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
These findings show for the first time that adriamycin can induce E-cadherin-mediated cell-cell adhesion by increasing expression of E-cadherin and beta-catenin and decreasing expression of MUC1 during breast cancer cell apoptosis induced by this drug.
|
10568816 |
1999 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Mucin 1 (MUC1) is a cell surface protein overexpressed in breast cancer.
|
28842375 |
2017 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The results showed significant differences in concentrations of the analyzed parameters and in levels of CA 15-3 between the groups of breast cancer patients and the two control groups.
|
26915610 |
2016 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In the human breast carcinoma cell line T47D, both compounds are able to stimulate transcription of a luciferase reporter gene under the control of a 750-base pair MUC1 promoter fragment proximal to the transcription start site.
|
11084045 |
2001 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
MUC1 is aberrantly expressed in greater than 90% of all breast carcinomas, yet its function as a tumor antigen is not fully understood.
|
12618757 |
2003 |